Foreign Filer Report • Aug 17, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
_________ false
| ����� ����������� ���� | 2 381 |
| ORAMED PHARMACEUTICALS INC | |
| Corporation no: 980376008 | 12537 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 17/08/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-060977 | Time of broadcast: 13:09 13:09 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | Form 13G |
20250817_Oramed_13G_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 06/08/2024 |
| Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004 | |
| E-mail address: [email protected] Company site: www.oramed.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company: | |
| Address: Mamilla 20 , Jerusalem 9414904 Telephone: 052-5779725 Facsimile: 02-5660004 E-mail: [email protected] 1 | |
| USA |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.